Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all-trans retinoic acid: Modulating effects of dihydroxylated vitamin D3, α interferon and 'stem cell factor'

Dario Ferrero, Nadia Carlesso, Paola Bresso, Viviana Roux, Patrizia Pregno, Eugenio Gallo, Alessandro Pileri

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In a liquid culture system, all-trans retinoic acid (ATRA), alone and in combination with dihydroxylated vitamin D3 (D3) or α interferon (αIFN) at concentrations achievable in vivo, could significantly suppress the maintenance of non-promyelocytic myeloid leukemia clonogenic cells (CFU-L) in 9/20, 9/18 and 7/11 cases, respectively. That suppression was counteracted only slightly by the addition of 'stem cell factor', a cytokine which promotes CFU-L expansion in vitro. Differentiated cells slightly increased in 5/17 cases only, suggesting the prevalence of anti-proliferative rather than differentiating mechanisms. The present results extend our previous ones and suggest the possible therapeutical value of ATRA+D3 or αIFN, even in cases of non-promyelocytic myeloid leukemia.

Original languageEnglish (US)
Pages (from-to)51-58
Number of pages8
JournalLeukemia Research
Volume21
Issue number1
DOIs
StatePublished - Jan 1 1997

Fingerprint

Stem Cell Factor
Myeloid Leukemia
Cholecalciferol
Tretinoin
Interferons
Maintenance
Cytokines
In Vitro Techniques

Keywords

  • Acute myeloid leukemia
  • Clonogenic cells
  • Dihydroxylated vitamin D3
  • Retinoic acid
  • Stem cell factor
  • α interferon

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all-trans retinoic acid : Modulating effects of dihydroxylated vitamin D3, α interferon and 'stem cell factor'. / Ferrero, Dario; Carlesso, Nadia; Bresso, Paola; Roux, Viviana; Pregno, Patrizia; Gallo, Eugenio; Pileri, Alessandro.

In: Leukemia Research, Vol. 21, No. 1, 01.01.1997, p. 51-58.

Research output: Contribution to journalArticle

@article{2bd9fdca8ba941f7bd2221bcf159fd4d,
title = "Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all-trans retinoic acid: Modulating effects of dihydroxylated vitamin D3, α interferon and 'stem cell factor'",
abstract = "In a liquid culture system, all-trans retinoic acid (ATRA), alone and in combination with dihydroxylated vitamin D3 (D3) or α interferon (αIFN) at concentrations achievable in vivo, could significantly suppress the maintenance of non-promyelocytic myeloid leukemia clonogenic cells (CFU-L) in 9/20, 9/18 and 7/11 cases, respectively. That suppression was counteracted only slightly by the addition of 'stem cell factor', a cytokine which promotes CFU-L expansion in vitro. Differentiated cells slightly increased in 5/17 cases only, suggesting the prevalence of anti-proliferative rather than differentiating mechanisms. The present results extend our previous ones and suggest the possible therapeutical value of ATRA+D3 or αIFN, even in cases of non-promyelocytic myeloid leukemia.",
keywords = "α interferon, Acute myeloid leukemia, Clonogenic cells, Dihydroxylated vitamin D3, Retinoic acid, Stem cell factor",
author = "Dario Ferrero and Nadia Carlesso and Paola Bresso and Viviana Roux and Patrizia Pregno and Eugenio Gallo and Alessandro Pileri",
year = "1997",
month = "1",
doi = "10.1016/S0145-2126(96)00066-5",
language = "English (US)",
volume = "21",
pages = "51--58",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all-trans retinoic acid

T2 - Modulating effects of dihydroxylated vitamin D3, α interferon and 'stem cell factor'

AU - Ferrero, Dario

AU - Carlesso, Nadia

AU - Bresso, Paola

AU - Roux, Viviana

AU - Pregno, Patrizia

AU - Gallo, Eugenio

AU - Pileri, Alessandro

PY - 1997/1/1

Y1 - 1997/1/1

N2 - In a liquid culture system, all-trans retinoic acid (ATRA), alone and in combination with dihydroxylated vitamin D3 (D3) or α interferon (αIFN) at concentrations achievable in vivo, could significantly suppress the maintenance of non-promyelocytic myeloid leukemia clonogenic cells (CFU-L) in 9/20, 9/18 and 7/11 cases, respectively. That suppression was counteracted only slightly by the addition of 'stem cell factor', a cytokine which promotes CFU-L expansion in vitro. Differentiated cells slightly increased in 5/17 cases only, suggesting the prevalence of anti-proliferative rather than differentiating mechanisms. The present results extend our previous ones and suggest the possible therapeutical value of ATRA+D3 or αIFN, even in cases of non-promyelocytic myeloid leukemia.

AB - In a liquid culture system, all-trans retinoic acid (ATRA), alone and in combination with dihydroxylated vitamin D3 (D3) or α interferon (αIFN) at concentrations achievable in vivo, could significantly suppress the maintenance of non-promyelocytic myeloid leukemia clonogenic cells (CFU-L) in 9/20, 9/18 and 7/11 cases, respectively. That suppression was counteracted only slightly by the addition of 'stem cell factor', a cytokine which promotes CFU-L expansion in vitro. Differentiated cells slightly increased in 5/17 cases only, suggesting the prevalence of anti-proliferative rather than differentiating mechanisms. The present results extend our previous ones and suggest the possible therapeutical value of ATRA+D3 or αIFN, even in cases of non-promyelocytic myeloid leukemia.

KW - Acute myeloid leukemia

KW - Clonogenic cells

KW - Dihydroxylated vitamin D3

KW - Retinoic acid

KW - Stem cell factor

KW - α interferon

UR - http://www.scopus.com/inward/record.url?scp=0031037073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031037073&partnerID=8YFLogxK

U2 - 10.1016/S0145-2126(96)00066-5

DO - 10.1016/S0145-2126(96)00066-5

M3 - Article

C2 - 9029186

AN - SCOPUS:0031037073

VL - 21

SP - 51

EP - 58

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 1

ER -